Peru vs Sri Lanka: Number of isolates tested for ceftriaxone
Peru
32
in 2020
Sri Lanka
24
in 2018
Peru rank
39th
Sri Lanka rank
42nd
Number of isolates tested for ceftriaxone over time
- Peru
- Sri Lanka
How they compare
Peru currently reports 32 against 24 in Sri Lanka, a difference of 8.
That makes Peru's figure about 1.3 times Sri Lanka's.
The two have swapped places 1 time across 6 shared years of data; in 2009 it was Sri Lanka ahead.
Peru ranks 39th and Sri Lanka ranks 42nd of 52 countries.
Sri Lanka has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Peru | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40 | 72 | 32 | Sri Lanka |
| 2010s | 51 | 71.8 | 20.8 | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Peru or Sri Lanka?
- Peru, at 32 against 24 in Sri Lanka as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Peru and Sri Lanka?
- 8, with Peru ahead.
- How many years of comparable data are there for Peru and Sri Lanka?
- 6 years are reported by both, from 2009 to 2018.
- How do Peru and Sri Lanka rank globally for number of isolates tested for ceftriaxone?
- Peru ranks 39th and Sri Lanka ranks 42nd of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.